1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Li Xiao Wei: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| HAIC Combine Tislelizumab and Lenvatinib in the Treatment of HCC With Type IV (Vp4) Portal Vein Tumor Thrombus (HAI-TL) Tislelizumab, Lenvatinib - Hepatocellular Carcinoma With PVTT | Phase 2 | Unknown | Li Xiao Wei | 54 | 2024-03-01 | 2024-02-20 |
lenvatinib (1) · tislelizumab (1)
China (1)
Jian Zhai, MM (1)